{
  "5029384_syn_1": "Indication: RLL nodule + Adenopathy.\nProcedures: EBUS-TBNA + Ion Nav + Cryobiopsy.\nEBUS: 10R positive (Adeno). 4L neg.\nIon: Navigated to RLL mass. REBUS/CBCT confirmed.\nSampling: Forceps x6, Cryo x2.\nROSE: Adenocarcinoma (Primary & N1).\nPlan: Staging workup.",
  "5029384_syn_2": "PROCEDURE: Combined endobronchial ultrasound and robotic-assisted bronchoscopy. EBUS-TBNA was performed at stations 4L and 10R; station 10R was positive for malignancy. The Ion robotic platform was then utilized to navigate to the RLL superior segment mass. Following radial EBUS and Cone-Beam CT confirmation, both conventional forceps biopsies and transbronchial cryobiopsies were obtained to ensure adequate tissue for molecular profiling.",
  "5029384_syn_3": "Billing: 31653 (EBUS 3+ stations - note says 4L, 10R sampled, plus others surveyed/considered?), 31627 (Nav), 31654 (REBUS), 31628 (TBBx), 31623 (Brush).\nCorrection: Note lists sampling of 4L and 10R only (2 stations). Should be 31652. Cryobiopsy (31628 covers TBBx method broadly or 31645 if distinct).",
  "5029384_syn_4": "Combined EBUS/Robotic Bronch\nPatient: [REDACTED]\nIndication: RLL mass + nodes\nSteps:\n1. EBUS: Sampled 4L (neg) and 10R (pos).\n2. Ion Robot: Navigated to RLL mass.\n3. Confirmed with REBUS + CBCT.\n4. Biopsies: Forceps and Cryo.\n5. Bleeding controlled with blocker.\nResult: Stage IIIA Adeno (T1cN1).",
  "5029384_syn_5": "Michelle needs staging for her RLL mass. Did EBUS first sampled 4L and 10R. 10R was positive for adeno. Then switched to the Ion robot found the RLL mass with rebus and cone beam. Took forceps biopsies and then two cryo biopsies for molecular. Had some bleeding used a blocker and iced saline. Patient stable.",
  "5029384_syn_6": "EBUS with TBNA, Ion robotic bronchoscopy, Radial EBUS, Cryobiopsy of RLL mass. Patient is a 71-year-old female. EBUS Phase: Sampled stations 4L and 10R. ROSE positive for malignancy at 10R. Ion Robotic Bronchoscopy Phase: Navigated to RLL superior segment mass. Radial EBUS and CBCT confirmed position. Forceps biopsies and cryobiopsies obtained. Mild bleeding managed with blocker. Final staging likely IIIA.",
  "5029384_syn_7": "[Indication]\nRLL mass, mediastinal adenopathy.\n[Anesthesia]\nGeneral, ETT.\n[Description]\nEBUS-TBNA (4L, 10R). Ion Nav to RLL. REBUS/CBCT confirmation. Forceps and Cryobiopsy of mass. 10R and Mass positive for Adenocarcinoma.\n[Plan]\nMolecular testing. Oncology consult.",
  "5029384_syn_8": "We performed a comprehensive staging procedure for [REDACTED]. First, we used EBUS to sample lymph nodes; the right hilar node tested positive for cancer. Then, using the robotic bronchoscope, we biopsied the main tumor in the right lower lobe using both standard forceps and a freezing probe to get a large sample for genetic testing. She is diagnosed with Stage IIIA adenocarcinoma and will need further treatment planning.",
  "5029384_syn_9": "Procedure: Multimodal staging bronchoscopy.\nComponents: EBUS-TBNA of hilar/mediastinal nodes. Robotic navigation with cryosampling of pulmonary parenchymal lesion.\nFindings: N1 nodal involvement and primary adenocarcinoma confirmed.\nIntervention: Hemostasis secured via bronchial blocker.",
  "5029384": "PROCEDURE NOTE:\n68 y.o. male with 60 pack-year smoking history presents with LLL mass on staging CT. PET shows SUV 8.9. Mediastinal nodes negative. Patient consented for diagnostic bronch and fiducial placement for possible SBRT.\n\nIntubated by anesthesia without difficulty. ETT 8.0 at 23 cm.\n\nVENT: VC, TV 500, RR 14, PEEP 5, FiO2 45%, Flow 55, Pmean 11\n\nCT from [REDACTED] loaded to Ion station. Navigation plan created to LLL superior segment mass. Automatic registration completed. Fiducial error 1.4mm - acceptable.\n\nIon catheter deployed. Initial navigation showed 8mm deviation at target - reregistration performed with improved accuracy (error 0.9mm).\n\nRadial probe inserted through Ion working channel. Eccentric pattern visualized - lesion 36mm diameter. Probe withdrawn, biopsy tools inserted.\n\nObtained:\n• 8 transbronchial biopsies (formalin)\n• 3 brush specimens (cytopathology)\n• Bronchial washings (cytology, AFB, fungal, bacterial cx)\n\nROSE: highly cellular, malignant cells consistent with squamous cell carcinoma\n\nFiducial marker (0.8x3mm gold CIVCO) placed in LLL anterior segmental bronchus under fluoroscopy - confirmed adequate position for radiation planning.\n\nPost-procedure: hemostasis confirmed, no bleeding. Patient extubated, stable vitals, transferred to recovery.\n\nPLAN: Multidisciplinary tumor board discussion. Likely SBRT candidate given node-negative disease. F/u 1 week.\n**Bronchoscopy Report**\n\nThompson Memorial Hospital\nDepartment of Interventional Pulmonology\n\nPt [REDACTED]: Lee, Catherine Y. | Age: 72 | Sex: F\nMedical Record: [REDACTED] | Date: [REDACTED]\nAttending: Dr. Rebecca Hoffman | Fellow: Dr. James Park\n\n**Chief Complaint:** Incidental pulmonary nodule\n\n**HPI:** Patient with history of breast cancer (2018, in remission) found to have 1.8cm RML nodule on surveillance CT. PET shows mild uptake SUV 2.8. Presents for tissue diagnosis.\n\n**Procedure Performed:** Robotic bronchoscopy (Intuitive Ion platform), radial endobronchial ultrasound, transbronchial biopsy\n\n**Informed Consent:** Reviewed risks of bleeding (1-5%), pneumothorax (1-2%), infection, need for chest tube, respiratory compromise. Patient consented.\n\n**Anesthesia:** GETA by Dr. Steven Kim. MAC #7.5 ETT, depth 21cm at teeth.\n\n**Ventilator Parameters:** SIMV, Rate 12, Vt 400mL, PEEP 5, FiO2 50%, I:E 1:2\n\n**Technique:**\nPreoperative CT dated [REDACTED] uploaded to Ion planning workstation. Virtual pathway generated to RML medial segment nodule.\n\nRegistration protocol: Automatic method employed. Carina, RUL/RML/RLL carinas, and segmental bifurcations matched. Global alignment quality: excellent. Mean fiducial registration error: 1.1mm.\n\nIon robotic catheter navigated along planned trajectory. Distance to target: 0.8cm at final position.\n\nRadial EBUS probe (1.4mm) inserted - demonstrated concentric hypoechoic pattern, lesion diameter 17mm, well-circumscribed borders.\n\nCBCT performed (NaviLink 3D fusion): Overlay confirmed catheter within lesion volume. Margin from lesion center: 2mm.\n\n**Samples obtained:**\n- TBBx x 5 (histopathology)\n- Cytology brush x 2\n- BAL from RML (cell count, micro)\n\n**ROSE:** Adequate sample. Bronchioloalveolar cells, no malignancy id[REDACTED] in initial review. (Final cytology pending)\n\n**Findings:**\n- Upper airway: normal\n- Trachea: patent, no masses\n- Carina: sharp, mobile\n- Right bronchial tree: patent, no endobronchial lesions\n- Left bronchial tree: not fully examined given unilateral target\n\n**Complications:** None\n**EBL:** Minimal\n**Condition:** Stable, extubated, to PACU\n\n**Assessment/Plan:**\nSuccessful robotic bronchoscopy with biopsy of RML nodule. ROSE shows no definitive malignancy but final pathology pending. If benign, plan for 3-month interval CT surveillance per Fleischner criteria. Patient to follow up in clinic 2 weeks for pathology review.\n\nElectronically signed: R. Hoffman MD - [REDACTED] 16:45"
}
